|Articles|October 15, 2002
- BioPharm International-10-01-2002
- Volume 15
- Issue 10
FDA Launches Major CGMP Review
Author(s)Jill Wechsler
by Jill Wechsler Agency officials are reexamining manufacturing standards and plant inspection processes.
Advertisement
Articles in this issue
about 23 years ago
Process Validation: How Much to Do and When to Do Itabout 23 years ago
Biotech Will Recover!about 23 years ago
GMPs and Pharmaceutical Labelingabout 23 years ago
Revolutionizing Biologics RegulationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
